Literature DB >> 20932476

ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress.

Zhao-Hui Wu1, Ee Tsin Wong, Yuling Shi, Jixiao Niu, Zhijian Chen, Shigeki Miyamoto, Vinay Tergaonkar.   

Abstract

Activation of the transcription factor NF-κB by multiple genotoxic stimuli modulates cancer cell survival. This response is mediated by a conserved pathway involving the nuclear ATM kinase and cytoplasmic IκB kinase (IKK); however, the molecular link between them remains incompletely understood. Here we show that ATM activates the IKK kinase TAK1 in a manner dependent on IKKγ/NEMO and ELKS (a protein rich in glutamate, leucine, lysine, and serine). K63-linked polyubiquitination of ELKS, dependent on the ubiquitin ligase XIAP and the conjugating enzyme UBC13, allows ELKS association with TAK1 via its ubiquitin-binding subunits TAB2/3. Although NEMO mutants defective in ubiquitin binding permit ATM-dependent TAK1 activation, they block NEMO association with ELKS and IKK activation. Thus, ATM- and NEMO-dependent ubiquitination of ELKS leads to the ubiquitin-dependent assembly of TAK1/TAB2/3 and NEMO/IKK complexes, resulting in IKK and NF-κB activation following genotoxic stimuli.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20932476      PMCID: PMC3048026          DOI: 10.1016/j.molcel.2010.09.010

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  48 in total

1.  Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.

Authors:  L Deng; C Wang; E Spencer; L Yang; A Braun; J You; C Slaughter; C Pickart; Z J Chen
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  TAK1 is a ubiquitin-dependent kinase of MKK and IKK.

Authors:  C Wang; L Deng; M Hong; G R Akkaraju; J Inoue ; Z J Chen
Journal:  Nature       Date:  2001-07-19       Impact factor: 49.962

Review 3.  Missing pieces in the NF-kappaB puzzle.

Authors:  Sankar Ghosh; Michael Karin
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

4.  A family of RIM-binding proteins regulated by alternative splicing: Implications for the genesis of synaptic active zones.

Authors:  Yun Wang; Xinran Liu; Thomas Biederer; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

5.  Differential expression of multiple isoforms of the ELKS mRNAs involved in a papillary thyroid carcinoma.

Authors:  Tomoko Nakata; Takashi Yokota; Mitsuru Emi; Shiro Minami
Journal:  Genes Chromosomes Cancer       Date:  2002-09       Impact factor: 5.006

6.  Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1.

Authors:  D Q Yang; M B Kastan
Journal:  Nat Cell Biol       Date:  2000-12       Impact factor: 28.824

7.  ATM is required for IkappaB kinase (IKKk) activation in response to DNA double strand breaks.

Authors:  N Li; S Banin; H Ouyang; G C Li; G Courtois; Y Shiloh; M Karin; G Rotman
Journal:  J Biol Chem       Date:  2000-12-12       Impact factor: 5.157

8.  NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain.

Authors:  E Laplantine; E Fontan; J Chiaravalli; T Lopez; G Lakisic; M Véron; F Agou; Alain Israël
Journal:  EMBO J       Date:  2009-09-17       Impact factor: 11.598

9.  Direct activation of protein kinases by unanchored polyubiquitin chains.

Authors:  Zong-Ping Xia; Lijun Sun; Xiang Chen; Gabriel Pineda; Xiaomo Jiang; Anirban Adhikari; Wenwen Zeng; Zhijian J Chen
Journal:  Nature       Date:  2009-08-12       Impact factor: 49.962

10.  Cast: a novel protein of the cytomatrix at the active zone of synapses that forms a ternary complex with RIM1 and munc13-1.

Authors:  Toshihisa Ohtsuka; Etsuko Takao-Rikitsu; Eiji Inoue; Marie Inoue; Masakazu Takeuchi; Kaho Matsubara; Maki Deguchi-Tawarada; Keiko Satoh; Koji Morimoto; Hiroyuki Nakanishi; Yoshimi Takai
Journal:  J Cell Biol       Date:  2002-08-05       Impact factor: 10.539

View more
  105 in total

1.  Alternative nuclear functions for NF-κB family members.

Authors:  Lluís Espinosa; Anna Bigas; Maria Carmen Mulero
Journal:  Am J Cancer Res       Date:  2011-02-16       Impact factor: 6.166

2.  RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors.

Authors:  S E Martin; Z-H Wu; K Gehlhaus; T L Jones; Y-W Zhang; R Guha; S Miyamoto; Y Pommier; N J Caplen
Journal:  Curr Cancer Drug Targets       Date:  2011-10       Impact factor: 3.428

Review 3.  The DNA damage-induced cell death response: a roadmap to kill cancer cells.

Authors:  Sonja Matt; Thomas G Hofmann
Journal:  Cell Mol Life Sci       Date:  2016-01-20       Impact factor: 9.261

Review 4.  Nuclear initiated NF-κB signaling: NEMO and ATM take center stage.

Authors:  Shigeki Miyamoto
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

5.  Survivin Inhibitors Mitigate Chemotherapeutic Resistance in Breast Cancer Cells by Suppressing Genotoxic Nuclear Factor-κB Activation.

Authors:  Wei Wang; Bo Zhang; Arul M Mani; Zhongzhi Wu; Yu Fan; Wei Li; Zhao-Hui Wu
Journal:  J Pharmacol Exp Ther       Date:  2018-05-07       Impact factor: 4.030

Review 6.  Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation.

Authors:  Sujatha Muralidharan; Pranoti Mandrekar
Journal:  J Leukoc Biol       Date:  2013-08-29       Impact factor: 4.962

7.  LUBAC regulates NF-κB activation upon genotoxic stress by promoting linear ubiquitination of NEMO.

Authors:  Jixiao Niu; Yuling Shi; Kazuhiro Iwai; Zhao-Hui Wu
Journal:  EMBO J       Date:  2011-08-02       Impact factor: 11.598

8.  High throughput short interfering RNA (siRNA) screening of the human kinome identifies novel kinases controlling the canonical nuclear factor-κB (NF-κB) activation pathway.

Authors:  Sanjeev Choudhary; Kevin P Rosenblatt; Ling Fang; Bing Tian; Zhao-Hui Wu; Allan R Brasier
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

Review 9.  Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy.

Authors:  S Spiegel; S Milstien; S Grant
Journal:  Oncogene       Date:  2011-07-04       Impact factor: 9.867

10.  Copper is a potent inhibitor of both the canonical and non-canonical NFκB pathways.

Authors:  Niall S Kenneth; George E Hucks; Andrew J Kocab; Annie L McCollom; Colin S Duckett
Journal:  Cell Cycle       Date:  2014-02-03       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.